<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">An Bras Dermatol</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24937828</article-id>
      <article-id pub-id-type="pmc">4056712</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20142994</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Pityriasis Rubra Pilar and hypothyroidism<sup><xref ref-type="fn" rid="fn01">*</xref></sup>
</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Franzotti</surname>
            <given-names>Aline Martinez</given-names>
          </name>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Avelar</surname>
            <given-names>Juliana Centofanti Dentello</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cardoso</surname>
            <given-names>Tha&#xED;s Abr&#xE3;o</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pires</surname>
            <given-names>Mario Cesar</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Vidigal</surname>
            <given-names>Maria do Ros&#xE1;rio</given-names>
          </name>
        </contrib>
        <aff> Complexo Hospitalar Padre Bento de Guarulhos (CHPBG) - Guarulhos (SP),
Brazil.</aff>
      </contrib-group>
      <author-notes>
        <corresp id="c01">MAILING ADDRESS<bold>:</bold> Aline Martinez Franzotti, Avenida
Em&#xED;lio Ribas - 1819 Guarulhos, 07050-001 - S&#xE3;o Paulo - SP, Brazil. E-mail:
<email>alinefranzotti@yahoo.com.br</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>May-Jun</season>
        <year>2014</year>
      </pub-date>
      <volume>89</volume>
      <issue>3</issue>
      <fpage>497</fpage>
      <lpage>500</lpage>
      <history>
        <date date-type="received">
          <day>20</day>
          <month>7</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>18</day>
          <month>8</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution Non-Commercial License which permits
unrestricted non-commercial use, distribution, and reproduction in any
medium, provided the original work is properly cited. </license-p>
        </license>
      </permissions>
      <abstract>
        <p>Pityriasis Rubra Pilaris (PRP) is a chronic and rare papulosquamous disorder.
Treatment of Pityriasis Rubra Pilaris is based on empiric evidence because of
several doubts regarding its etiology and also because of its relative rarity,
making randomized studies difficult to perform. Some factors suggest that the
metabolism of vitamin A is involved in pathogenesis. We report a case of
Pityriasis Rubra Pilaris associated with autoimmune hypothyroidism which
presented rapid and complete response after thyroid hormone replacement, without
any association with other systemic treatment. In literature there are only
three other reports of significant improvement of the lesions after hormonal
correction. Deficiency of thyroid hormone inhibits the conversion of carotene
into vitamin A, which would be responsible for the occurrence of Pityriasis
Rubra Pilaris in this patient.</p>
      </abstract>
      <kwd-group>
        <kwd>Hypothyroidism</kwd>
        <kwd>Pityriasis rubra pilaris</kwd>
        <kwd>Therapeutics</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Pityriasis Rubra Pilaris is a chronic dermatosis of unknown etiology. Although there
are familial cases, the majority is acquired. It affects men and women in the same
proportion and presents bimodal incidence, with peaks on the 1<sup>st</sup> -
2<sup>nd</sup> and 5<sup>th</sup>- 6<sup>th</sup> decades.</p>
      <p>Griffiths proposed its classification in five groups based on clinical appearance,
behavior and prognosis.<sup><xref rid="r01" ref-type="bibr">1</xref></sup> Recently,
a sixth type was proposed, associated with HIV, typically refractory to the
treatment.<sup><xref rid="r02" ref-type="bibr">2</xref></sup></p>
      <p>The treatments adopted up to now are empiric, due to its unknown etiology. Currently,
the first-line therapy is the use of systemic retinoidsm which allow the clinical
improvement of the the patient due to its beneficial effect on disorders of
keratinization.<sup><xref rid="r03" ref-type="bibr">3</xref></sup></p>
      <p>The methotrexate is the second-line therapy. Other therapies include
immunosuppressors, such as azathioprine or cyclosporine, stanozolol, phototherapy,
extracorporeal photopheresis, fumaric acid, calcipotriol and the
biologicals.<sup><xref rid="r03" ref-type="bibr">3</xref>,<xref rid="r04" ref-type="bibr">4</xref>,<xref rid="r05" ref-type="bibr">5</xref></sup> All presented variable responses.</p>
      <p>Initially it was believed that vitamin A deficiency caused PRP. The possibilities of
infectious and autoimmune pathogenesis were also taken into account.<sup><xref rid="r03" ref-type="bibr">3</xref></sup></p>
      <p>We describe here a case of PRP associated with subclinical hypothyroidism with
presented significant improvement of lesions after a short period of Levothyroxine
use. Therefore, the importance of researching the alteration of thyroid function in
these patients is here emphasized.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>The patient was a white man, 30 years old, with erythemato-squamous plaques in a
follicular pattern affecting elbows, knees and back of hands, associated with
palmoplantar hyperkeratosis (<xref ref-type="fig" rid="f01">Figure 1</xref>).
Initially topical corticoids were used together with salicylic acid, with no
improvement. Referred to our service, a cutaneous biopsy was requested for
anatomopathological (AP) exam, the main diagnostic hypotheses being Psoriasis and
Pityriasis rubra pilaris. The first laboratory exams showed subclinical
hypothyroidism (TSH: 11.25mU/mL; T4L:1.08ng/dL) associated with hypertriglyceridemia
(235mg/dl). HIV serology was negative. It was decided to introduce levothyroxine
50mcg/day and refer the patient to the endocrinologist for follow-up. Only skin
hydration was maintained. AP showed ectasia and follicular hyperkeratosis, besides
lymphocytary superficial perivascular inflammatory infiltrate, favoring the clinical
proposition of Pityriasis Rubra Pilaris. A considerable improvement of the lesions
was noticed after only 30 days of hormone replacement (<xref ref-type="fig" rid="f02">Figure 2</xref>). It was opted to follow-up with only cutaneous
hydration and adjustment of thyroid function. The subsequent follow-up showed
progressive improvement of lesions (<xref ref-type="fig" rid="f03">Figure
3</xref>).</p>
      <fig id="f01" orientation="portrait" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p>Erythemato-squamous plaques with follicular pattern involving elbows, knees,
back of hands and trunk</p>
        </caption>
        <graphic xlink:href="abd-89-03-0497-g01"/>
      </fig>
      <fig id="f02" orientation="portrait" position="float">
        <label>FIGURE 2</label>
        <caption>
          <p>Significant improvement of lesions after 30 days of hormone replacement</p>
        </caption>
        <graphic xlink:href="abd-89-03-0497-g02"/>
      </fig>
      <fig id="f03" orientation="portrait" position="float">
        <label>FIGURE 3</label>
        <caption>
          <p>Clinical improvement after 3 months of hormonal control</p>
        </caption>
        <graphic xlink:href="abd-89-03-0497-g03"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>The not very clear pathogenesis of PRP is the main culprit for the multiple and
ineffective treatments employed. For many years PRP was associated with vitamin A
deficiency, hypothesis corroborated by its histological similarity to
hypovitaminosis A and the clinical improvement of patients after high doses of this
vitamin. However, vitamin A replacement fell into disuse due to its inconsistent
results. The frequent finding of normal serum levels of vitamin A suggests that
there would be a failure in its metabolism and not a deficiency.</p>
      <p>Vitamin A circulates in the human plasma as retinol, linked to a retinol binding
specific carrier protein (RBP).<sup><xref rid="r06" ref-type="bibr">6</xref></sup></p>
      <p>In the Finzi et al study a low level of this binding protein was found, which
suggests the decrease of retinol arrival to the epidermis, which would explain the
best clinical response with the use of topical vitamin A or retinoic acid (active
form of retinol) in comparison with parenteral and oral use of the
vitamin.<sup><xref rid="r06" ref-type="bibr">6</xref></sup></p>
      <p>Other authors believe in the alteration of the immune system due to its association
with other autoimmune diseases (myasthenia gravis, hypothyroidism and celiac
disease), malignancies (bronchogenic, renal cell and hepatocellular carcinomas) and
HIV infection.</p>
      <p>Hypothyroidism is directly linked to vitamin A metabolism alteration. The thyroid
hormone is fundamental to the conversion of ingested carotenes to vitamin A. The
hypothyroidism patients present almost total blockage of this conversion and only a
small amount of carotenoids, not converted to vitamin A, are absorbed by
humans.<sup><xref rid="r07" ref-type="bibr">7</xref></sup></p>
      <p>In this case, we show the dramatic improvement of lesions after thyroid hormone
correction, without the use of any other therapy. In the literature there are only 3
similar cases reported. The first was in 1964, in a review article.<sup><xref rid="r08" ref-type="bibr">8</xref></sup> Tunessen et al described the second
case of erythrodermic PRP in a 4-year-old child, associated with severe
hypothyroidism.<sup><xref rid="r07" ref-type="bibr">7</xref></sup> The last
described case we found was from Orlandini et al, about a 24-year-old man with
erythrodermic PRP who presented complete improvement of the clinical picture after 3
months of hormone replacement.<sup><xref rid="r09" ref-type="bibr">9</xref></sup></p>
      <p>We cannot discard clinical improvement as natural evolution of the disease, for
spontaneous remission can occur in up to 80% of the cases, specially in the
erythrodermic form; however, it only occurs after 1 to 3 years of evolution and
systemic treatments are normally necessary to hasten recovery. In all described
cases, clinical improvement was obtained, in average, 30 to 90 days after the start
of hormone replacement, without any association with other therapy, strongly
suggesting there is direct effect of this treatment on PRP.</p>
      <p>Hypothyroidism is also associated with cholesterol level changes. In our case,
besides hormone level changes, the increase of triglycerides (TG) was observed. The
deficiency of thyroid hormones diminishes the rate of TG removal.</p>
      <p>In literature some cases were described about patients whose TG serum level increased
after treatment with high doses of vitamin A. Nevertheless, the true causal relation
of this increase regarding treatment with vitamin A has been questioned. On these
studies cholesterol levels were not dosed before the start of treatment. Perhaps
these patients had already had their thyroid function altered and the simple
hormonal adjustment led to clinical improvement.<sup><xref rid="r10" ref-type="bibr">10</xref></sup></p>
      <p>Pityriasis rubra pilaris associated with hypothyroidism could be a particular subtype
of acquired PRP, such as the previously described association with HIV. This way, we
could assume that PRP would be the cutaneous clinical manifestation of metabolic
alteration of vitamin A, with acquired (infectious, autoimmune, paraneoplastic) or
familial causes (deficiency of RBP).</p>
      <p>To confirm such suppositions more studies with larger numbers of cases are necessary;
however, the relative rarity of this dermatosis makes it difficult.</p>
      <p>Notwithstanding, this association with hypothyroidism, although uncommon, must be
always investigated in the cases of PRP due to the spectacular effect of thyroid
hormone replacement and absence of collateral effects.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p>Conflict of interest: None</p>
      </fn>
      <fn fn-type="financial-disclosure">
        <p>Financial funding: None</p>
      </fn>
      <fn id="fn01" fn-type="other">
        <label>*</label>
        <p>Work performed at Complexo Hospitalar Padre Bento de Guarulhos (CHPBG) -
Guarulhos (SP), Brazil.</p>
      </fn>
      <fn fn-type="other">
        <p>How to cite this article: Franzotti AM, Avelar JCD, Cardoso TA, Pires MC, Vidigal
MR. Pityriasis Rubra Pilar and hypothyroidism. An Bras Dermatol.
2014;89(3):497-500.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES </title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Griffiths</surname>
              <given-names>WAD</given-names>
            </name>
          </person-group>
          <article-title>Pityriasis rubra pilaris</article-title>
          <source>Clin Exp Dermatol</source>
          <year>1980</year>
          <volume>5</volume>
          <fpage>105</fpage>
          <lpage>112</lpage>
          <pub-id pub-id-type="pmid">7398119</pub-id>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Miralles</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>N&#xFA;&#xF1;ez</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>De Las Heras</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>P&#xE9;rez</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Moreno</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Ledo</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Pityriasis rubra pilaris and human immunodeficiency virus
infection</article-title>
          <source>Br J Dermatol</source>
          <year>1995</year>
          <volume>133</volume>
          <fpage>990</fpage>
          <lpage>993</lpage>
          <pub-id pub-id-type="pmid">8547057</pub-id>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guimar&#xE3;es</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Belo</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Branco</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lobo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Duque</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Brito</surname>
              <given-names>F</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title xml:lang="pt">Pitir&#xED;ase rubra pilar: relato de caso com boa
resposta &#xE0; acitretina e revis&#xE3;o da literatura</article-title>
          <source>An Bras Dermatol</source>
          <year>2001</year>
          <volume>76</volume>
          <fpage>717</fpage>
          <lpage>721</lpage>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fox</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Odom</surname>
              <given-names>RB</given-names>
            </name>
          </person-group>
          <article-title>Papulosquamous diseases: a review</article-title>
          <source>J Am Acad Dermatol</source>
          <year>1985</year>
          <volume>12</volume>
          <fpage>597</fpage>
          <lpage>624</lpage>
          <pub-id pub-id-type="pmid">3157710</pub-id>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cohen</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Prystowsky</surname>
              <given-names>JH</given-names>
            </name>
          </person-group>
          <article-title>Pityriasis rubra pilaris: a review of diagnosis and
treatment</article-title>
          <source>J Am Acad Dermatol</source>
          <year>1989</year>
          <volume>20</volume>
          <fpage>801</fpage>
          <lpage>807</lpage>
          <pub-id pub-id-type="pmid">2654219</pub-id>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Finzi</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Altomare</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Bergamaschini</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Tucci</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Pityriasis rubra pilaris and retinolbinding
protein</article-title>
          <source>Br J Dermatol</source>
          <year>1981</year>
          <volume>104</volume>
          <fpage>253</fpage>
          <lpage>256</lpage>
          <pub-id pub-id-type="pmid">7194102</pub-id>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tunnessen</surname>
              <given-names>WW</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Nieburg</surname>
              <given-names>PI</given-names>
            </name>
            <name>
              <surname>Voorhess</surname>
              <given-names>ML</given-names>
            </name>
          </person-group>
          <article-title>Hypothyroidism and pityriasis rubra pilaris. Response to thyroid
hormone</article-title>
          <source>J Pediatr</source>
          <year>1976</year>
          <volume>88</volume>
          <fpage>456</fpage>
          <lpage>458</lpage>
          <pub-id pub-id-type="pmid">1245956</pub-id>
        </element-citation>
      </ref>
      <ref id="r08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gross</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Landau</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Newcomer</surname>
              <given-names>VD</given-names>
            </name>
          </person-group>
          <article-title>Pityriasis rubra pilaris. Report of a case and analysis of the
literature</article-title>
          <source>Arch Dermatol</source>
          <year>1969</year>
          <volume>99</volume>
          <fpage>710</fpage>
          <lpage>716</lpage>
          <pub-id pub-id-type="pmid">5783082</pub-id>
        </element-citation>
      </ref>
      <ref id="r09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Orlandini</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Cogrel</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Doutre</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Beylot</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Beylot-Barry</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Pityriasis rubra pilaris and hypothyroidism: Efficacy of thyroid
hormone replacement therapy in skin recovery</article-title>
          <source>Br J Dermatol</source>
          <year>2007</year>
          <volume>156</volume>
          <fpage>606</fpage>
          <lpage>607</lpage>
          <pub-id pub-id-type="pmid">17300270</pub-id>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kohn</surname>
              <given-names>SR</given-names>
            </name>
          </person-group>
          <article-title>Pityriasis rubra pilaris</article-title>
          <source>Arch Dermatol</source>
          <year>1984</year>
          <volume>120</volume>
          <fpage>995</fpage>
          <lpage>995</lpage>
          <pub-id pub-id-type="pmid">6465925</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
